R01: Implementing Scalable, PAtient-centered Team-based Care for Adults With Type 2 Diabetes (iPATH)
News and Interviews
- News_A Year of Trial Results and Innovations From the NIH Pragmatic Trials Collaboratory
December 15, 2025: A Year of Trial Results and Innovations From the NIH Pragmatic Trials Collaboratory
- News_Enrollment Begins for APA-SM and iPATH Trials
November 6, 2025: Enrollment Begins for APA-SM and iPATH Trials
- News_Study Snapshot and Updated Ethics Documentation Available for iPATH Trial
- News_iPATH Researchers Identify Factors Linked to Cardiovascular Care Performance in Community Health Centers
September 25, 2025: iPATH Researchers Identify Factors Linked to Cardiovascular Care Performance in Community Health Centers
- News_iPATH Team Explores Integration of Artificial Intelligence Into Analysis of Qualitative Data
March 20, 2025: iPATH Team Explores Integration of Artificial Intelligence Into Analysis of Qualitative Data
- News_iPATH Trial Aims to Improve Diabetes Care in Community Health Centers
August 26, 2024: iPATH Trial Aims to Improve Diabetes Care in Community Health Centers
- News_Ethics Consultation Documents Now Available for iPATH Trial
January 9, 2024: Ethics Consultation Documents Now Available for iPATH Trial
- News_NIH Pragmatic Trials Collaboratory Welcomes 5 New Demonstration Projects
October 31, 2023: NIH Pragmatic Trials Collaboratory Welcomes 5 New Trials
Overview
Principal Investigator:
Sponsoring Institution: Stanford University
Collaborators:
- Harvard University
- Ohio State University
- Impactivo, LLC
NIH Institute Providing Oversight: National Institute on Minority Health and Health Disparities (NIMHD)
Program Official: Dolly Penn, MD, MSCR (NIMHD)
Trial Summary
More than 37 million people in the United States have type 2 diabetes, and federally qualified health centers (FQHCs) shoulder a high prevalence of diabetes (21% in FQHCs vs 11% overall), offering a promising venue for innovating in diabetes care. The iPATH project will refine and implement an approach to practice transformation originally conceived to support FQHCs’ pursuit of National Committee for Quality Assurance recognition as patient-centered medical homes. A pilot study demonstrated significant decreases (average 31% reduction) in poorly controlled diabetes among patients at 7 clinics affiliated with 1 FQHC in 2017 to 2020. Improvements in patients’ diabetes control were sustained. For aim 1 of the iPATH project, the study team will refine the iPATH implementation approach by identifying organizational conditions and processes at FQHCs that promoted or impeded the effectiveness of type 2 diabetes care. They will conduct 12 in-depth regional case studies to differentiate between high-performing and low-performing FQHCs for diabetes control. Employing an innovative Rapid Data Collection and Reporting methodology, the study team will rapidly collect, analyze, and share data to accelerate dissemination of customized feedback to FQHC leaders and to inform adaptation and implementation of the iPATH practice transformation. For aim 2, the study team will implement a multilevel, multicomponent, technology-enabled practice transformation strategy to improve type 2 diabetes for patients at 8 multi-clinic FQHCs in California, Massachusetts, Ohio, and Puerto Rico. The implementation approach will be modularized and customizable to accommodate organizational readiness, patient needs, and social and environmental factors affecting patients’ health (such as transportation, employment, and nutrition), tailoring practice transformation efforts to each unique FQHC. For aim 3, the study team will evaluate the implementation approach using a stepped-wedge, cluster randomized, hybrid type 2 effectiveness-implementation trial. Using formative, process, and summative evaluation elements guided by the Exploration-Preparation-Implementation-Sustainment model, the trial will evaluate the impact of practice transformation and identify process elements affecting implementation effectiveness.
Data and Resource Sharing
- iPATH Ethics and Regulatory Follow-up
iPATH Ethics and Regulatory Follow-up
- iPATH Ethics and Regulatory Discussion
iPATH Ethics and Regulatory Discussion
Publications
- iPATH Study Snapshot
iPATH Study Snapshot
- Chevalier et al AJPM Focus 2025
Exploring characteristics associated with diabetes and hypertension performance in community health centers
- Ronaghi et al AcademyHealth Blog 2025
Integrating AI into qualitative analysis